12 month results of CALIBER: A phase II randomised feasibility trial of chemoablation with MMC versus surgical management in low risk (LR) non-muscle invasive bladder cancer (NMIBC)

2019 ◽  
Vol 18 (1) ◽  
pp. e762-e763
Author(s):  
H. Mostafid ◽  
N. Porta ◽  
J. Cresswell ◽  
T. Griffiths ◽  
J. Kelly ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Surgical Management ◽  
Phase Ii ◽  
Low Risk ◽  
Feasibility Trial ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

scholarly journals CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer

2020 ◽  
Vol 125 (6) ◽  
pp. 817-826 ◽  
Author(s):  
A. Hugh Mostafid ◽  
Nuria Porta ◽  
Joanne Cresswell ◽  
Thomas R.L. Griffiths ◽  
John D. Kelly ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Surgical Management ◽  
Phase Ii ◽  
Low Risk ◽  
Feasibility Trial ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

Can Gemcitabine Instillation Ablate Solitary Low-Risk Non-Muscle-Invasive Bladder Cancer? Results of a Phase II Marker Lesion Study

2011 ◽  
Vol 87 (4) ◽  
pp. 470-474 ◽  
Author(s):  
Maurizio A. Brausi ◽  
Paolo Gontero ◽  
Vincenzo Altieri ◽  
Renzo Colombo ◽  
Ilaria Conti ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Phase Ii ◽  
Low Risk ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

Reduced recurrence of low‐risk non‐muscle‐invasive bladder cancer is associated with low urine‐specific gravity

2020 ◽  
Vol 27 (11) ◽  
pp. 1019-1023
Author(s):  
Tomohiro Iwasawa ◽  
Naoya Niwa ◽  
Kazuhiro Matsumoto ◽  
Akari Komatsuda ◽  
Hiroki ide ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Specific Gravity ◽  
Low Risk ◽  
Invasive Bladder Cancer ◽  
Urine Specific Gravity ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive
Sign in / Sign up

Export Citation Format

Share Document